Professor Sidi Bencherif has developed a biomaterial-based platform that could be leveraged for COVID-19 vaccine development. Bencherif’s strategy is based on an injectable biomaterial that is able to slowly release SARS-CoV-2 antigens and adjuvants, which are substances that enhance the body’s immune response to antigens. This technology has potential both to prevent and treat infections.
Professor Tali Konry and her colleagues are working to adapt ScanDrop, a microchip-based technology developed at Northeastern, to detect the novel coronavirus in a manner that will be cheaper, faster, and easier to use than anything currently available.
Professor Seth Cooper has developed Foldit, an online puzzle game that is helping him to crowdsource ideas for the folding of proteins. This virtual research on proteins can be used in COVID-related work to identify the right structure for a vaccine.
Northeastern’s pharmaceutical scientists are becoming increasingly recognized as frontrunners in developing reliable and robust testing, as well as in the design and delivery of innovative and effective treatments. Our faculty researchers—and the discoveries that originate in their labs—continue to do critical work during a challenging and pivotal time and hold the skills and knowledge to change the course of this pandemic and future pandemics.